|
New
heart device raises risk of fatal blood infection
Patients
with pacemakers and other implanted heart devices are at risk of
a life-threatening bacterial blood infection, new study findings
suggest. In many patients who developed staphylococcus aureus bacteremia
(staph infection) and had a cardiac device implanted, the device
was the source of the infection. Often, these patients had no obvious
signs of infection, even after undergoing echocardiography, a procedure
that allows doctors to view the heart, according to reports from
the Journal of the American Heart Association.
The
authors suggest that based on the study findings, doctors treating
patients who develop staph infections and have heart devices, should
suspect that the device itself has become infected and consider
surgically removing it, rather than treating the blood infection
with antibiotics. In the study, conducted by researchers at Duke
University, Durham, North Carolina, patients who did not have the
device removed were more likely to die than patients who underwent
the surgery to have their device taken out. In patients with
staphylococcus aureus bacteremia and an implanted cardiac device,
the likelihood that the device is infected is high, especially in
the first year after the device is placed, Dr Anna Lisa Chamis,
the studys lead author, told Reuters Health. Physicians
must be more vigilant in seeking out device infection with echocardiography
and blood cultures, even if the physical examination does not suggest
cardiac device infection. The Duke researchers found that
15 of 33 patients with an implanted heart device developed a staph
infection in the blood within 6 years. Nine of these patients developed
the infection within their first year of living with the device.
In three of the nine patients, the infection originated in another
part of the body and spread to the heart device, while six cases
were caused by the device itself, the report indicates. In most
cases, there were no obvious signs that the device was infected,
such as redness or inflammation in the tissues covering the device,
Chamis and colleagues report. The infections were diagnosed on the
basis of blood tests. According to the researchers, cardiac device
infection of one kind or another occurs in up to 20 per cent of
patients with a permanent pacemakera small battery-operated
device that helps the heart beat regularly, and in up to 1.3 per
cent of those with an implantable cardioverter-defibrillators, which
shocks the heart into a normal rhythm.
(Source:Reuters
Health)
|